Internal Medicine, Gastroenterology · Tavares, FL
NPI
1851423701
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
1879 Nightingale Ln Ste B2
Tavares, FL, 32778
Phone (386) 231-1281
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
626 services
Medicare patients, 2024
266
Average age 70
Drug cost, 2024
$3.1M
656 prescriptions
Company payments, 2025
$29K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ilan Aharoni was code 99232 (hospital e&m - subsequent), 191 times for 90 patients. In total Ilan Aharoni billed 626 services in 31 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 191 | 90 | $59.90 | $11K |
| 99221 Hospital E&M - Initial | Facility | 88 | 87 | $61.16 | $5,382 |
| 43239 Upper GI Endoscopy | Facility | 78 | 78 | $74.01 | $5,773 |
| 45380 Lower GI Endoscopy - Other | Facility | 59 | 58 | $91.91 | $5,423 |
| 99213 Office E&M - Established | Office | 51 | 43 | $66.31 | $3,382 |
| 99214 Office E&M - Established | Office | 44 | 30 | $89.92 | $3,957 |
| 45385 Colonoscopy - Lesion Removal | Facility | 28 | 28 | $178.64 | $5,002 |
| 99203 Office E&M - New | Office | 19 | 19 | $82.35 | $1,565 |
By year: 2022 $62K for 684 services; 2023 $53K for 615 services; 2024 $51K for 626 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ilan Aharoni prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 51 prescriptions and refills. In total Ilan Aharoni wrote 656 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 51 | 51 | 49 | $3,072 |
| Stelara Ustekinumab | 50 | 66 | Under 11 | $1.4M |
| Omeprazole Generic | 44 | 120 | 21 | $1,029 |
| Entyvio Vedolizumab | 41 | 49 | Under 11 | $359K |
| Rinvoq Upadacitinib | 37 | 37 | Under 11 | $394K |
| Famotidine Generic | 28 | 72 | Under 11 | $514 |
| Mesalamine Generic | 25 | 59 | 11 | $10K |
| Linzess Linaclotide | 24 | 54 | 11 | $29K |
| Xifaxan Rifaximin | 23 | 31 | 11 | $90K |
| Skyrizi On-Body Risankizumab-Rzaa | 17 | 26 | Under 11 | $356K |
| Pantoprazole Sodium Generic | 15 | 39 | Under 11 | $127 |
| Skyrizi Risankizumab-Rzaa | 14 | 14 | Under 11 | $143K |
| Dexlansoprazole Dr Dexlansoprazole | 14 | 36 | Under 11 | $4,714 |
| Sodium Chloride 0.9 % Sodium Chloride | 13 | 18 | Under 11 | $28.4 |
| Ondansetron Odt Ondansetron | 13 | 13 | Under 11 | $207 |
Brand drugs: - claims; generic drugs: 362 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ilan Aharoni $29K ($29K in general payments such as food, travel and fees) from 11 companies. The largest payer was Pfizer Inc. with $17K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 12 | $17K |
| Abbvie Inc. ABBV | 32 | $8,669 |
| Celltrion USA Inc. 068270.KS | 4 | $3,897 |
| Janssen Biotech, Inc. JNJ | 2 | $61.01 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $53.09 |
| Lilly USA, LLC LLY | 2 | $40.58 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $37.07 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $24.4 |
| Novo Nordisk Inc NVO | 1 | $24.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.